Correlation Between Terns Pharmaceuticals and Lantern Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Lantern Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Lantern Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Lantern Pharma, you can compare the effects of market volatilities on Terns Pharmaceuticals and Lantern Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Lantern Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Lantern Pharma.

Diversification Opportunities for Terns Pharmaceuticals and Lantern Pharma

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Terns and Lantern is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Lantern Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lantern Pharma and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Lantern Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lantern Pharma has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Lantern Pharma go up and down completely randomly.

Pair Corralation between Terns Pharmaceuticals and Lantern Pharma

Given the investment horizon of 90 days Terns Pharmaceuticals is expected to generate 0.7 times more return on investment than Lantern Pharma. However, Terns Pharmaceuticals is 1.42 times less risky than Lantern Pharma. It trades about -0.11 of its potential returns per unit of risk. Lantern Pharma is currently generating about -0.13 per unit of risk. If you would invest  651.00  in Terns Pharmaceuticals on August 29, 2024 and sell it today you would lose (63.00) from holding Terns Pharmaceuticals or give up 9.68% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Terns Pharmaceuticals  vs.  Lantern Pharma

 Performance 
       Timeline  
Terns Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Terns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Lantern Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lantern Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Terns Pharmaceuticals and Lantern Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Terns Pharmaceuticals and Lantern Pharma

The main advantage of trading using opposite Terns Pharmaceuticals and Lantern Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Lantern Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lantern Pharma will offset losses from the drop in Lantern Pharma's long position.
The idea behind Terns Pharmaceuticals and Lantern Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital